Micrographia Bio
Micrographia Bio is an applied AI-first life sciences company focused on revolutionizing drug discovery through spatial proteomics. Their mission is to create a new era in medicine development by understanding protein-protein networks within cells, which they believe is key to determining how medicines work. Their deeptech imaging platform utilizes a novel strategy for highly multiplexed microscopy combined with state-of-the-art machine-intelligent computer vision to provide rapid and accurate drug discovery, identifying the true mechanism of action for potential therapeutics. The company is advancing its own therapeutic candidates targeting fundamental cellular pathways, aiming to significantly improve the success rate of drug discovery.
Micrographia Bio
Micrographia Bio is an applied AI-first life sciences company focused on revolutionizing drug discovery through spatial proteomics. Their mission is to create a new era in medicine development by understanding protein-protein networks within cells, which they believe is key to determining how medicines work. Their deeptech imaging platform utilizes a novel strategy for highly multiplexed microscopy combined with state-of-the-art machine-intelligent computer vision to provide rapid and accurate drug discovery, identifying the true mechanism of action for potential therapeutics. The company is advancing its own therapeutic candidates targeting fundamental cellular pathways, aiming to significantly improve the success rate of drug discovery.